Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD and Morphine for Pain Sensitivity (CMP)
NCT04030442Phase 1Recruiting
- Sponsor
- Wayne State University
- Start
- May 2019
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabidiol in chronic pain, sponsored by Wayne State University. Primary endpoint: Change in Pain Threshold and Tolerance. Started May 2019; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT04030442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030442.